Traditional diagnostic models for MASH, such as NFS and FIB-4, rely on standard liver enzymes like AST and ALT but often lack sufficient accuracy and specificity for MASH, particularly in distinguishing it from other causes of liver disease. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.